The Middle East Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Gazette.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 16, 2026

Mar. 16, 2026

Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

GlobeNewswire

Mar. 16, 2026

K2 Corporate Mobility’s growth leads the company to rebrand 

EIN Presswire

Mar. 16, 2026

Pan American Energy Commences Drilling at the Tharsis Project

GlobeNewswire

Mar. 16, 2026

Maxus Mining Confirms Strong Polymetallic Results at the Quarry Antimony Property in British Columbia, Canada

GlobeNewswire

Mar. 16, 2026

Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

GlobeNewswire

Mar. 16, 2026

Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

GlobeNewswire

Mar. 16, 2026

Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update

GlobeNewswire

Mar. 16, 2026

DPM Metals Announces Renewal of Normal Course Issuer Bid

GlobeNewswire

Mar. 16, 2026

Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

GlobeNewswire

Mar. 16, 2026

Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial

GlobeNewswire

Mar. 16, 2026

Enlight Secures $304 Million in Project Financing for the Crimson Orchard Project in Idaho, USA

GlobeNewswire

Mar. 16, 2026

Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026

GlobeNewswire

Mar. 16, 2026

Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire

Mar. 16, 2026

GFM Announces Non-Brokered Private Placement

GlobeNewswire

Mar. 16, 2026

Relay Therapeutics Announces Data from Zovegalisib + Fulvestrant at the Phase 3 Dose of 400mg BID Fed at ESMO Targeted Anticancer Therapies Congress 2026

GlobeNewswire

Mar. 16, 2026

Tower Semiconductor Teams up with Oriole to Advance AI Infrastructure and Networking with Nanosecond Optical Circuit Switching

GlobeNewswire

Mar. 16, 2026

Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

GlobeNewswire

Mar. 16, 2026

Allot to Participate in the 38th Annual Roth Conference on March 23-24, 2026

GlobeNewswire

Mar. 16, 2026

Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio

GlobeNewswire

Mar. 16, 2026

Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting

GlobeNewswire